|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||53.90 - 54.37|
|52-week range||50.37 - 62.96|
|Beta (5Y monthly)||0.17|
|PE ratio (TTM)||22.92|
|Forward dividend & yield||1.91 (3.55%)|
|Ex-dividend date||04 Nov 2021|
|1y target est||N/A|
GSK banks on stronger offer for its consumer healthcare business. Analysis: drugmaker appears to be holding out for what would be one of largest ever deals in London after rejecting Unilever bids
Unilever has launched a takeover bid for GlaxoSmithKline’s £50bn toiletries and over-the-counter medicines arm, in an attempt to boost its sluggish growth and tackle shareholder unrest.
What is the point of Hellmann’s mayonnaise? It depends on who you ask.